Trial reportEuropean geriatric medicine2026
Enhancement of muscle strength in older people using smart leggings with focal muscle vibration technology.
Trial report in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundWearable technologies focused on maintaining strength in older people are limited. A low-cost smart legging for daily use was developed, designed to stimulate the lower limbs through focal muscle vibration. The objective was to determine the effect of Myoviber® Smart Leggings with focal muscle vibration devices (MSLv) on knee extensor muscle strength in older people. The effect on participants with or without frailty was also determined.
methodsRandomized, controlled experimental design. Healthy older people from the community (sample size analyzed, n = 52), distributed in an experimental group (EG, n = 29; 69 ± 4 years) treated with MSLv and a control group (CG, n = 23; 69 ± 4 years) treated with sham MSLv. Both groups used the respective MSLv at home for 30 days, for three continuous hours. Three 10 min doses of MSLv were administered along with the activities of daily living guide. Knee extensor strength was measured with a transducer before and after the intervention. Data were analyzed with two-way ANOVA and Bonferroni post hoc test.
resultsMuscle strength increased in both groups post-intervention, with a significant relative increase in the EG (p < 0.01) but not in the CG (p = 0.225). Participants classified as having pre-frailty or frailty conditions in the EG showed greater strength gains than their counterparts in the CG (p < 0.05).
conclusionThe use of MSLv increases knee extensor muscle strength in older people, particularly those with pre-frailty or frailty conditions. MSLv is an innovative, practical solution that integrates health technologies for older adults.
Indexed as
Identifiers
41511633What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.